Drugmaker Pfizer Limited has announced the appointment of Meenakshi Nevatia as an Additional Director and Managing Director for five years. She comes in the place of S Sridhar, who announced his early retirement in August 2022. Sridhar, the current India country President, will step down as Managing Director and board member from March 31, 2023.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Meenakshi has 30 years of experience across companies including Mckinsey & Co, Novartis Pharmaceuticals, and more recently with Stryker Corporation. She has worked in over 8 countries (developed and emerging) and has held several General Management roles across multiple markets such as Thailand, Spain (Iberia) and India. Meenakshi received her Bachelor’s in Science (Economics) from Presidency College, Kolkata, India and completed her Post Graduate Diploma in Management from the highly acclaimed Indian Institute of Management Ahmedabad (IIMA).
The Board of Directors of Pfizer Limited, at their meeting held on 9 th February 2023, considered the recommendation of the Nomination & Remuneration Committee, and approved the appointment of Meenakshi as the Managing Director w.e.f. 3rd April 2023.
Important takeaways for all competitive exams:
Ethanol emerged as largest ethanol feedstock for the first time in ethanol program of the…
Uber is partnering with the Adani Group to build its first data centre in the…
The BRICS Foreign Ministers Meeting begins on 14th May, 2026 in the New Delhi. It…
Indian FinTech company FinBox has launched the Atlas which is an AI-native lending infrastructure platform…
The State government of Assam has approved the Uniform Civil Code (UCC) Bill. Along side…
The Reserve Bank of India (RBI) has cancelled the license of Sarvodaya Co-operative Bank Ltd.…